title: Research Progress of Platelet Transfusion in China.
abstract: Platelet products have been increasingly used for more than 50 years. Platelet transfusion is effective for correcting bleeding caused by thrombocytopenia and platelet function defects. In this review, we will outline research on platelet transfusion in China including platelet biosafety, cryopreservation of platelets, the assessment of the effectiveness of platelet transfusion, the causes of platelet transfusion refractoriness including immunization against CD36, and neonatal alloimmune thrombocytopenia.
authors.affiliation: Shengjing Hospital of China Medical University, Shenyang, China.
authors.forename: Qiushi
authors.initials: Q
authors.lastname: Wang
authors.affiliation: Shanxi Provincial People's Hospital, Xian, China.
authors.forename: Jiangcun
authors.initials: J
authors.lastname: Yang
authors.affiliation: University of Massachusetts Boston, Boston, MA.
authors.forename: Lori
authors.initials: L
authors.lastname: Stevens
authors.affiliation: Chinese PLA General Hospital, Beijing, China. Electronic address: deqingw@vip.sina.com.
authors.forename: Deqing
authors.initials: D
authors.lastname: Wang
mesh_terms: D035843:Biomedical Research / Q000379:methods / Q000639:trends*; D001793:Blood Preservation / Q000379:methods / Q000639:trends; D058731:Blood Safety / Q000379:methods / Q000639:trends; D002681:China; D006801:Humans; D017713:Platelet Transfusion / Q000379:methods / Q000639:trends*; D064826:Transfusion Medicine / Q000379:methods / Q000639:trends*
keywords: CD36; China; Cryopreservation of platelets; Neonatal alloimmune thrombocytopenia; Platelet transfusion; platelet refractoriness